Your browser doesn't support javascript.
loading
Novel Compounds Targeting Neuropilin Receptor 1 with Potential To Interfere with SARS-CoV-2 Virus Entry.
Perez-Miller, Samantha; Patek, Marcel; Moutal, Aubin; Duran, Paz; Cabel, Carly R; Thorne, Curtis A; Campos, Samuel K; Khanna, Rajesh.
Afiliação
  • Perez-Miller S; Department of Pharmacology, College of Medicine, The University of Arizona, Tucson, Arizona 85724, United States.
  • Patek M; The Center for Innovation in Brain Sciences, The University of Arizona Health Sciences, Tucson, Arizona 85704, United States.
  • Moutal A; Bright Rock Path Consulting, LLC, Tucson, Arizona 85704, United States.
  • Duran P; Department of Pharmacology, College of Medicine, The University of Arizona, Tucson, Arizona 85724, United States.
  • Cabel CR; Department of Pharmacology, College of Medicine, The University of Arizona, Tucson, Arizona 85724, United States.
  • Thorne CA; Department of Cellular & Molecular Medicine, College of Medicine, The University of Arizona, Tucson, Arizona 85724, United States.
  • Campos SK; Cancer Biology Graduate Interdisciplinary Program, University of Arizona, Tucson, Arizona 85724, United States.
  • Khanna R; Department of Cellular & Molecular Medicine, College of Medicine, The University of Arizona, Tucson, Arizona 85724, United States.
ACS Chem Neurosci ; 12(8): 1299-1312, 2021 04 21.
Article em En | MEDLINE | ID: mdl-33787218
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neuropilina-1 / COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neuropilina-1 / COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article